Authors: Van Eck, M Van Dijk, KW Herijgers, N Hofker, MH Groot, PHE Van Berkel, TJC

Citation: M. Van Eck et al., Essential role for the (hepatic) LDL receptor in macrophage apolipoproteinE-induced reduction in serum cholesterol levels and atherosclerosis, ATHEROSCLER, 154(1), 2001, pp. 103-112

Authors: Van Eck, M Herijgers, N Van Dijk, KW Havekes, LM Hofker, MH Groot, PHE Van Berkel, TJC

Citation: M. Van Eck et al., Effect of macrophage-derived mouse apoE, human apoE3-Leiden, and human apoE2 (Arg158 -> Cys) on cholesterol levels and atherosclerosis in apoE-deficient mice, ART THROM V, 20(1), 2000, pp. 119-127

Authors: Van Dijk, KW Hofker, MH Havekes, LM

Citation: Kw. Van Dijk et al., Use of transgenic mice to study the role of apolipoprotein E in lipid metabolism and atherosclerosis, INT J TISS, 22(2-3), 2000, pp. 49-58

Authors: de Winther, MPJ Gijbels, MJJ Van Dijk, KW Havekes, LM Hofker, MH

Citation: Mpj. De Winther et al., Transgenic mouse models to study the role of the macrophage scavenger receptor class A in atherosclerosis, INT J TISS, 22(2-3), 2000, pp. 85-91

Authors: Jong, MC Van Dijk, KW Dahlmans, VEH Van der Boom, H Kobayashi, K Oka, K Siest, G Chan, L Hofker, MH Havekes, LM

Citation: Mc. Jong et al., Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor, BIOCHEM J, 338, 1999, pp. 281-287